EX-10.1 2 dex101.htm SUBLICENSE AGREEMENT SUBLICENSE AGREEMENT BETWEEN REVIMMUNE, LLC AND ACCENTIA BIOPHARMACEUTICALS, INC.Sublicense Agreement • May 5th, 2020 • Florida
Contract Type FiledMay 5th, 2020 JurisdictionThis Sublicense Agreement (this “Agreement or “Sublicense Agreement”) effective as of February 27, 2007, by and between Revimmune, LLC, a Florida limited liability company, (“Revimmune”), and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, (“Accentia”) (collectively the “Parties”).
SUBLICENSE AGREEMENT BETWEEN REVIMMUNE, LLC AND ACCENTIA BIOPHARMACEUTICALS, INC.Sublicense Agreement • February 28th, 2007 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 28th, 2007 Company Industry JurisdictionThis Sublicense Agreement (this “Agreement or “Sublicense Agreement”) effective as of February 27, 2007, by and between Revimmune, LLC, a Florida limited liability company, (“Revimmune”), and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, (“Accentia”) (collectively the “Parties”).